BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6783500)

  • 1. Effect of human granulocytic elastase on isolated human antithrombin III.
    Jochum M; Lander S; Heimburger N; Fritz H
    Hoppe Seylers Z Physiol Chem; 1981 Feb; 362(2):103-12. PubMed ID: 6783500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage and inactivation of Factor IX by granulocyte elastase.
    Takaki A; Enfield DL; Thompson AR
    J Clin Invest; 1983 Nov; 72(5):1706-15. PubMed ID: 6605369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Properties of thrombin- and elastase-modified human antithrombin III.
    Gettins P; Harten B
    Biochemistry; 1988 May; 27(10):3634-9. PubMed ID: 3408716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathobiochemistry of sepsis: role of proteinases, proteinase inhibitors and oxidizing agents.
    Jochum M; White J; Duswald KH; Inthorn D; Welter H; Fritz H
    Behring Inst Mitt; 1986 Feb; (79):121-30. PubMed ID: 3521575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
    Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
    Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymatic inactivation of human antithrombin III. Limited proteolysis of the inhibitor by snake venom proteinases in the presence of heparin.
    Kress LF; Catanese J
    Biochim Biophys Acta; 1980 Sep; 615(1):178-86. PubMed ID: 7426659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin promotes the inactivation of antithrombin by neutrophil elastase.
    Jordan RE; Kilpatrick J; Nelson RM
    Science; 1987 Aug; 237(4816):777-9. PubMed ID: 3649921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elastases from human and canine granulocytes, II. Interaction with protease inhibitors of animal, plant, and microbial origin.
    Schiessler H; Ohlsson K; Olsson I; Arnhold M; Birk Y; Fritz H
    Hoppe Seylers Z Physiol Chem; 1977 Jan; 358(1):53-8. PubMed ID: 300070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of the elastase-like enzyme of the bovine granulocyte.
    Marossy K; Hauck M; Elödi P
    Biochim Biophys Acta; 1980 Sep; 615(1):237-45. PubMed ID: 6903450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of tryptophan modification upon digestion of antithrombin III by elastase.
    Scully MF; Shah N; Ellis V; Kakkar VV
    Thromb Haemost; 1991 Apr; 65(4):351-4. PubMed ID: 2057915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of human granulocytic elastase alpha 1-proteinase inhibitor complex (E-alpha 1-PI) in leukemia.
    Hiller E; Jochum M
    Blut; 1984 May; 48(5):269-75. PubMed ID: 6372901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin-induced proteolysis of human antithrombin III: an outstanding contribution of heparin.
    Marciniak E
    Br J Haematol; 1981 Jun; 48(2):325-36. PubMed ID: 7236529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteinase inhibitors in severe inflammatory processes (septic shock and experimental endotoxaemia): biochemical, pathophysiological and therapeutic aspects.
    Fritz H
    Ciba Found Symp; 1979; (75):351-79. PubMed ID: 399895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of elastase from granulocytes by the low molecular weight bronchial protease inhibitor.
    Ohlsson K; Tegner H
    Scand J Clin Lab Invest; 1976 Sep; 36(5):437-45. PubMed ID: 185683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of human antithrombin by neutrophil elastase. Kinetics of the heparin-dependent reaction.
    Jordan RE; Nelson RM; Kilpatrick J; Newgren JO; Esmon PC; Fournel MA
    J Biol Chem; 1989 Jun; 264(18):10493-500. PubMed ID: 2732232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo catabolism of heparin cofactor II and its complex with thrombin: evidence for a common receptor-mediated clearance pathway for three serine proteinase inhibitors.
    Pratt CW; Church FC; Pizzo SV
    Arch Biochem Biophys; 1988 Apr; 262(1):111-7. PubMed ID: 3258496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential role of fractionated heparin in antithrombin-III proteolysis.
    Marciniak E
    Blood; 1982 Mar; 59(3):576-81. PubMed ID: 7037067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of human mast cell tryptase with biological protease inhibitors.
    Alter SC; Kramps JA; Janoff A; Schwartz LB
    Arch Biochem Biophys; 1990 Jan; 276(1):26-31. PubMed ID: 1688695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.